Posted on 11-26-2012
A recent study published in the Archives of Internal Medicine October 2012 tracked a total of 434 new active substances (NASs) approved by Health Canada between 1995 and 2010. The NASs were then compared to see whether a difference in safety existed between those that had gone through Health Canada's standard 300-day review period vs. the 180-day priority process. Drugs streamed into Health Canada's accelerated review process are 15% more likely to be withdrawn from the market or to earn a serious safety warning. This of course falls on the fact that 85% of the drugs passed by the FDA are recalled shortly after they pass after post market analysis (us being the guinea pigs).
In all reality we should be staying away from medications and taking care of our own health before it deteriorates. Are you ready for that challenge in 2013? Make an appointment and lets talk about it!
Have a blessed day!
There are no comments for this post. Please use the form below to post a comment.